Evolus (NASDAQ:EOLS) Stock Price & Analysis

–

USD

–(–)

Open

$6.90

Prev. Close

$7.91

High

$7.01

Low

$6.86

Company Profile

Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.

CEODavid Moatazedi

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Employees353

IPO DateFeb 8, 2018

ExchangeNASDAQ

Exchange NameNASDAQ Global Market

CurrencyUSD

Headquarters & Contact

Address520 Newport Center Drive

City / State / ZIPNewport Beach, CA, 92660

CountryUnited States

Phone949 284 4555

Websitehttps://www.evolus.com

Evolus, Inc.

Company Profile

Recently from Cashu